We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma.AuthorsAlgazi AP; Weber JS; Andrews SC; Urbas P; Munster PN; DeConti RC; Hwang J; Sondak VK; Messina JL; McCalmont T; Daud AIPublicationBritish journal of cancer, 2012, Vol 106, Issue 1, p85ISSN1532-1827Publication typearticleDOI10.1038/bjc.2011.514